Moneta Group Investment Advisors’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$895K Sell
11,173
-217
-2% -$17.9K 0.01% 377
2025
Q4
$971K Sell
11,390
-4,804
-30% -$394K 0.01% 366
2025
Q3
$1.26M Buy
16,194
+3,770
+30% +$295K 0.01% 310
2025
Q2
$972K Sell
12,424
-2,106
-14% -$157K 0.01% 314
2025
Q1
$1.05M Buy
14,530
+316
+2% +$22.6K 0.01% 285
2024
Q4
$1.05M Sell
14,214
-330
-2% -$23.1K 0.01% 277
2024
Q3
$960K Sell
14,544
-622
-4% -$45.2K 0.01% 285
2024
Q2
$1.4M Sell
15,166
-19
-0.1% -$1.68K 0.02% 228
2024
Q1
$1.45M Buy
15,185
+281
+2% +$23.6K 0.02% 225
2023
Q4
$1.14M Sell
14,904
-22
-0.1% -$1.53K 0.02% 224
2023
Q3
$1.03M Buy
14,926
+601
+4% +$48.3K 0.02% 218
2023
Q2
$1.35M Sell
14,325
-797
-5% -$69.3K 0.03% 201
2023
Q1
$1.25M Buy
15,122
+318
+2% +$25K 0.03% 198
2022
Q4
$1.1M Buy
14,804
+148
+1% +$11.4K 0.03% 195
2022
Q3
$1.21M Sell
14,656
-1,034
-7% -$99.5K 0.05% 177
2022
Q2
$1.49M Buy
15,690
+1,793
+13% +$186K 0.05% 168
2022
Q1
$1.64M Sell
13,897
-98
-0.7% -$11K 0.06% 154
2021
Q4
$1.81M Buy
13,995
+940
+7% +$110K 0.07% 142
2021
Q3
$1.48M Sell
13,055
-1,795
-12% -$205K 0.07% 151
2021
Q2
$1.54M Sell
14,850
-23
-0.2% -$2.17K 0.07% 154
2021
Q1
$1.24M Buy
+14,873
New +$1.26M 0.07% 156
2018
Q1
Sell
-9
Closed 645
2017
Q4
$0 Buy
+9
New +$330 ﹤0.01% 490
2015
Q4
Sell
-1,062
Closed -$25K 228
2015
Q3
$25K Buy
+1,062
New +$25.6K 0.01% 296

Other funds holding EW

Moneta Group Investment Advisors's EW Position: Q1 2026 in Review

Moneta Group Investment Advisors reduced its Edwards Lifesciences (EW) stake by 1.9% in Q1 2026, selling an estimated $17.9K and leaving 11,173 shares worth $895K. The position accounts for 0.01% of the portfolio, ranked #377.

Moneta Group Investment Advisors first reported a position in EW in Q3 2015 and has held it in 23 quarters since. The position peaked at $1.81M in Q4 2021. 1,285 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Moneta Group Investment Advisors held 11,173 shares of Edwards Lifesciences worth $895K as of Q1 2026.
  • Moneta Group Investment Advisors sold 217 Edwards Lifesciences shares in Q1 2026, an estimated $17.9K.
  • Edwards Lifesciences made up 0.01% of Moneta Group Investment Advisors's portfolio in Q1 2026, its #377 holding.
  • Moneta Group Investment Advisors first reported a position in Edwards Lifesciences in Q3 2015 and has held it in 23 quarters since.
  • Moneta Group Investment Advisors's Edwards Lifesciences position peaked at $1.81M in Q4 2021.
  • 1,285 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Moneta Group Investment Advisors's 13F filing for Q1 2026, filed 12 May 2026.